The microglial immunoreceptor tyrosine-based motif-Syk signaling pathway is a promising target of immunotherapy for Alzheimer's disease

Clin Transl Med. 2023 Feb;13(2):e1200. doi: 10.1002/ctm2.1200.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / therapy
  • Humans
  • Immunotherapy
  • Microglia / metabolism
  • Signal Transduction
  • Syk Kinase / metabolism
  • Tyrosine* / metabolism

Substances

  • Tyrosine
  • SYK protein, human
  • Syk Kinase